✦ LIBER ✦

Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

✍ Scribed by Charu Aggarwal; Sameer Gupta; William P. Vaughan; Gene B. Saylors; Donna E. Salzman; Rhonda O. Katz; Amy G. Nance; Arabella B. Tilden; Matthew H. Carabasi

Book ID: 116279019
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 170 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.03.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superior survival after replacing oral w

Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide

✍ Robert M. Dean; Brad Pohlman; John W. Sweetenham; Ronald M. Sobecks; Matt E. Kal 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Busulfan and Cyclophosphamide (Bu/Cy) as

Busulfan and Cyclophosphamide (Bu/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience

✍ Matthew Ulrickson; Julie Aldridge; Haesook T. Kim; Ephraim P. Hochberg; Peter Ha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Multicenter study of intravenous busulfa

Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma

✍ Kim, J G; Sohn, S K; Chae, Y S; Yang, D H; Lee, J-J; Kim, H-J; Shin, H J; Jung, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB